Clinical trial imaging offers information on human anatomy varying from undeniable interpretable information to information that is of uncertain value.  The global clinical trial imaging market is projected to reach $1378.7 Million by 2024 from $795.4 Million in 2017, at a CAGR of 6.9%. The clinical inferences of an image are used in evaluating the drug effect and are used on a daily basis to prevent, detect, treat and manage various diseases or medical conditions. The rise in R&D spending and an increase in pharmaceutical and biotechnology industries are the drivers that boost the growth of the market. On the flip side, the rise in implementation imaging cost and the high cost of clinical trials are the restraints that hamper the growth of the market. Emerging economies and development of multimodality imaging technology are the opportunities for the clinical trials market.

Research Study Objectives:

• Define, estimate, and forecast the Clinical Trial Imaging market statistics by products & services, modality, end user and regions concerning the individual growth drivers, market trends and their contribution toward the Clinical Trial Imaging market growth
• Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
• Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
• Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Clinical Trial Imaging Market Analysis
• Analysis and conclusions on the future Clinical Trial Imaging market outlook.

Top-down and bottom-up approaches are used to validate the Clinical Trial Imaging Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Clinical Trial Imaging Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Clinical Trial Imaging market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.

The scope of the Report

The Clinical Trial Imaging market segmentation is as follows:

By Products & Services

• Services
• Software

By Modality

• Computed Tomography
• Magnetic Resonance Imaging
• Ultrasound
• Positron Emission Tomography
• X-Ray
• Echocardiography
• Other Modalities

By End User

• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Manufacturers
• Contract Research Organizations
• Academic and Government Research Institutes
• Other End Users

Geographical Analysis:

Clinical Trial Imaging Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.

Customization Options:

With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Clinical Trial Imaging Market include:

• Scope Revision
• Geographic Analysis
• Company Profiles
• Historical Data & Forecasting
• Key Contact Persons in companies

Global Clinical Trial Imaging Market Research Report Includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOT analysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
• Identifying DROC in the current market and their impact on altering market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the significant Clinical Trial Imaging market players, such as
  • Bioclinica, Inc.
  • Icon PLC
  • Biotelemetry, Inc.
  • Intrinsic Imaging LLC
  • Ixico PLC
• Along with these companies, many other companies are considered in the report while analysing the Global Clinical Trial Imaging competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.